Alcon (ALC) Liabilities and Shareholders Equity (2009 - 2026)

Alcon (ALC) posted quarterly Liabilities and Shareholders Equity of $31.6 billion for Q1 2026, little changed on a QoQ basis from $31.6 billion in Q4 2025.

Alcon (ALC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Alcon (ALC) has reported Liabilities and Shareholders Equity for 11 consecutive years, with $31.6 billion the latest figure, recorded in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $31.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.1 billion (up 39.43% YoY) and the FY2025 annual result came in at $31.6 billion, up 3.98% from the prior year.
  • Liabilities and Shareholders Equity was little changed at $31.6 billion in Q1 2026 per ALC's latest filing, from $31.6 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for ALC reached as high as $31.6 billion in Q1 2026 and fell as low as $27.7 billion in Q2 2022.
  • A 5-year average of $29.8 billion and a median of $29.6 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity retreated 0.08% — and 2023, when it advanced 5.66%.
  • Year by year, Liabilities and Shareholders Equity stood at $29.2 billion in 2022, then increased by 1.54% to $29.6 billion in 2023, then increased by 2.48% to $30.3 billion in 2024, then gained by 3.98% to $31.6 billion in 2025, then advanced by 0.2% to $31.6 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $31.6 billion, $31.6 billion, and $31.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 31.62 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 20.88 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 50.83 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 39.01 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 8.78 Bn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 4.08 Bn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 12.48 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 14.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 6.31 Bn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn 19.85 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 31.62 Bn
Dec 31, 2025 31.56 Bn
Sep 30, 2025 31.52 Bn
Jun 30, 2025 31.39 Bn
Dec 31, 2024 30.35 Bn
Sep 30, 2024 30.36 Bn
Jun 30, 2024 29.72 Bn
Mar 31, 2024 29.57 Bn
Dec 31, 2023 29.61 Bn
Sep 30, 2023 29.37 Bn
Jun 30, 2023 29.21 Bn
Mar 31, 2023 29.29 Bn
Dec 31, 2022 29.17 Bn
Sep 30, 2022 27.80 Bn
Jun 30, 2022 27.73 Bn
Mar 31, 2022 27.79 Bn
Dec 31, 2021 28.00 Bn
Sep 30, 2021 27.80 Bn
Jun 30, 2021 27.75 Bn
Mar 31, 2021 27.37 Bn